Seroprevalence and estimation of the impact of SARS-CoV-2 infection in older adults residing in Long-term Care Facilities in Chile

被引:0
|
作者
Rubilar, Paola [1 ]
Hirmas, Macarena [1 ]
Matute, Isabel [1 ]
Browne, Jorge [2 ]
Little, Cedric [3 ]
Ruz, Gonzalo [3 ]
Aguilera, Ximena [1 ]
Avila, Carlos [4 ]
Vial, Pablo [5 ]
Mackenzie, Tania Gutknecht [6 ]
机构
[1] Clin Alemana Univ Desarrollo, Fac Med, Ctr Epidemiol & Polit Salud, Santiago, Chile
[2] Serv Nacl Adulto Mayor, Santiago, Chile
[3] Univ Adolfo Ibanez, Fac Ingn & Ciencias, Santiago, Chile
[4] Minist Ciencia Tecnol Conocimiento & Innovac, Santiago, Chile
[5] Clin Alemana Univ Desarrollo, Inst Ciencias & Innovac Med ICIM, Fac Med, Santiago, Chile
[6] Fdn Chile, Santiago, Chile
来源
MEDWAVE | 2022年 / 22卷 / 03期
关键词
COVID-19 Serological Testing; Long-Term Care; aged; SARS-CoV-2; CORONAVIRUS DISEASE 2019;
D O I
10.5867/medwave.2022.03.002553
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction Older adults are at a higher risk of severe illness and death from COVID-19. This vulnerability increases in those who live in long-term care facilities due to overcrowding, greater physical dependence, and contact with health workers. Evidence on the impact of the pandemic on these establishments in low- and middle-income countries has been scant. This study aims to determine the seroprevalence of SARS-CoV-2 in older people residing in long-term care facilities and estimate the impact of infection after the first wave of the pandemic. Methods A cross-sectional design with 2099 residents in three regions of Chile was carried out between September and November 2020. Measurement of antibodies was performed with a rapid test. The impact of SARS-CoV-2 infection was estimated with seropositive residents, those who had a history of positive polymerase chain reaction tests, and those who died from COVID-19. Bivariate analysis with the region, sex, age, history of COVID-19, physical dependence, and serological results were performed. In addition, we performed a correlation analysis between the seroprevalence of the centers by the municipality and the rate of confirmed cases. Results The seroprevalence of SARS-CoV-2 antibodies in the three regions was 14.7% (95% confidence interval: 13.2 to 16.3%), the infection impact was 46.4%, and the fatality rate was 19.6%. A significant correlation was found between the seroprevalence of older adults residing in long-term care facilities and the cumulative incidence by municipalities. Conclusions The seroprevalence of older adults residing in long-term care facilities was higher than the general population. The high impact of infection among this population at the end of the first wave of the COVID-19 pandemic is similar to other countries. The centers' environment is directly related to COVID-19 infection. Morbidity and mortality monitoring systems should be implemented promptly to establish prevention and control measures.
引用
收藏
页数:11
相关论文
共 50 条
  • [1] Asymptomatic SARS-CoV-2 infection in Belgian long-term care facilities
    Hoxha, Ana
    Wyndham-Thomas, Chloe
    Klamer, Sofieke
    Dubourg, Dominique
    Vermeulen, Melissa
    Hammami, Naima
    Cornelissen, Laura
    LANCET INFECTIOUS DISEASES, 2021, 21 (04): : E67 - E67
  • [2] Antibody Seroprevalence, Infection and Surveillance for SARS-CoV-2 in Residents and Staff of New Jersey Long-Term Care Facilities
    Stephen M. Friedman
    Amy L. Davidow
    Manisha Gurumurthy
    Reza Peymani
    John Webb
    Keya Desai
    Richard Siderits
    Anna Nepomich
    Edward Lifshitz
    Pauline A. Thomas
    Journal of Community Health, 2022, 47 : 774 - 782
  • [3] Antibody Seroprevalence, Infection and Surveillance for SARS-CoV-2 in Residents and Staff of New Jersey Long-Term Care Facilities
    Friedman, Stephen M.
    Davidow, Amy L.
    Gurumurthy, Manisha
    Peymani, Reza
    Webb, John
    Desai, Keya
    Siderits, Richard
    Nepomich, Anna
    Lifshitz, Edward
    Thomas, Pauline A.
    JOURNAL OF COMMUNITY HEALTH, 2022, 47 (05) : 774 - 782
  • [4] When to opt for preemptive anticoagulation with SARS-CoV-2 infection in the long-term care facilities
    Mujahid, Nadia
    Rajan, Ashna
    Abul, Yasin
    Vura, Naga Venkata Rama Krishna
    Neupane, Iva
    LaPlante, Kerry
    Gravenstein, Stefan
    AGING CLINICAL AND EXPERIMENTAL RESEARCH, 2022, 34 (12) : 3171 - 3177
  • [5] When to opt for preemptive anticoagulation with SARS-CoV-2 infection in the long-term care facilities
    Nadia Mujahid
    Ashna Rajan
    Yasin Abul
    Naga Venkata Rama Krishna Vura
    Iva Neupane
    Kerry LaPlante
    Stefan Gravenstein
    Aging Clinical and Experimental Research, 2022, 34 : 3171 - 3177
  • [6] Estimating SARS-CoV-2 seroprevalence in long-term care: a window of opportunity
    Verschoor, Chris P.
    Bowdish, Dawn M. E.
    LANCET GLOBAL HEALTH, 2022, 3 (01): : E2 - E3
  • [7] Estimating SARS-CoV-2 seroprevalence in long-term care: a window of opportunity
    Verschoor, Chris P.
    Bowdish, Dawn M. E.
    LANCET HEALTHY LONGEVITY, 2022, 3 (01): : E2 - E3
  • [8] Spread of a Variant SARS-CoV-2 in Long-Term Care Facilities in England
    Krutikov, Maria
    Hayward, Andrew
    Shallcross, Laura
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (17): : 1671 - 1673
  • [9] The Role of Staff in Transmission of SARS-CoV-2 in Long-term Care Facilities
    Adams, Carly
    Chamberlain, Allison
    Wang, Yuke
    Hazell, Mallory
    Shah, Sarita
    Holland, David P.
    Khan, Fazle
    Gandhi, Neel R.
    Fridkin, Scott
    Zelner, Jon
    Lopman, Benjamin A.
    EPIDEMIOLOGY, 2022, 33 (05) : 669 - 677
  • [10] Prevalence of SARS-CoV-2 among Belgian workers in long-term care facilities
    Mylle, G.
    Vanacker, H.
    Verbeek, C.
    Bulterys, S.
    Godderis, L.
    De Schryver, A.
    OCCUPATIONAL MEDICINE-OXFORD, 2021, 71 (6-7): : 290 - 293